Regulatory and Economic Aspects in Oncology
This book explores a wide range of topics of importance to all those who have an interest in economic methods for assessment of the efficacy and effectiveness of new cancer treatments and in regulatory measures relating to the marketing authorization and pricing of such treatments. It also examines...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
| Έκδοση: | 1st ed. 2019. |
| Σειρά: | Recent Results in Cancer Research,
213 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- The growing health burden of cancer: a global epidemiological overview.-Cost of Cancer Care: Health expenditures and economic impact
- Innovation in R&D: An answer to cancer
- The Evaluation of Benefits, Harms and Costs of Cancer Screening
- Oncology from a HTA and health economic perspective
- Heterogeneous recommendations for oncology products among different HTA systems: a comparative assessment
- Outcomes in oncology: clinical vs. patient-reported outcome performance measures
- The value of patient-reported outcome in health economic decision making: a changing landscape in oncology
- Approaches to capture value in oncology
- Orphan durgs in oncology
- Recent developments in health economic modeling of cancer therapies
- Drug pricing and value in oncology
- Pharmaceutical price regulation of cancer treatments
- Regulatory and evidence requirements and the changing landscape in regulation for marketing authorization
- Looking for Willingness to Pay (WTP) Threshold for a QALY in oncology
- Equity and patient access to innovative cancer treatments. .
